WASHINGTON ADVOCACY GROUP

Lobbying for AMGEN INC. · Biotechnology

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · Senate · $20,000.00 income · posted Jan 19, 2026

Lobbying activity 1

Health Issues

Monitor healthcare regulations and statutes and educate members of Congress on issues with regard to client's interests

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.